# Arcturus Therapeutics Holdings Inc.: Form 8-K, filed Jul 2, 2026

- Company: [Arcturus Therapeutics Holdings Inc.](/companies/arct.md) (CIK 1768224)
- Form: 8-K
- Filed: 2026-07-02
- Accepted by EDGAR: Jul 2, 2026, 07:05 ET
- Period: 2026-06-26
- Accession: 0001193805-26-000910
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1768224/000119380526000910/e665618_8k-arct.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1768224/000119380526000910/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1768224/000119380526000910/e665618_8k-arct.htm

Filed Jul 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001193805-26-000910. Last ingested by Listed: Nov 14, 2026, 14:45 ET. No prices; not investment advice.
